MNA
EW icon

Manning & Napier Advisors’s Edwards Lifesciences EW Stock Holding History

Manning & Napier Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.13K Buy
52
+29
+126% +$2.39K ﹤0.01% 524
2025
Q4 		$1.98K Buy
+23
New +$1.89K ﹤0.01% 490

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Manning & Napier Advisors's EW Position: Q1 2026 in Review

Manning & Napier Advisors increased its Edwards Lifesciences (EW) stake by 126% in Q1 2026, buying an estimated $2.39K and bringing the position to 52 shares worth $4.13K. The position accounts for ﹤0.01% of the portfolio, ranked #524.

Manning & Napier Advisors first reported a position in EW in Q4 2025 and has held it in 2 quarters since. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Manning & Napier Advisors held 52 shares of Edwards Lifesciences worth $4.13K as of Q1 2026.
  • Manning & Napier Advisors bought 29 Edwards Lifesciences shares in Q1 2026, an estimated $2.39K.
  • Edwards Lifesciences made up ﹤0.01% of Manning & Napier Advisors's portfolio in Q1 2026, its #524 holding.
  • Manning & Napier Advisors first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 2 quarters since.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Manning & Napier Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.